Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
Reva Medical Inc.
Bioresorbable stent maker Reva scores $85 million in IPO Down Under
Reva Medical Inc. reeled in $84.8 million in an initial public offering in Australia.
The San Diego-based bioresorbable stent developer’s shares are slated to begin trading on the Australian Securities Exchange under the RVA symbol Dec. 23.
Reva issued about 7.7 million new shares of common stock at $1.10 Australian, according to the company.